与伊朗癌症后治疗青少年的健康相关的感知脆弱性:内容分析
Masumeh Akbarbegloo1, Mahnaz Sanaeefar2, Mehrdad Karimi3
1Department of Nursing, Faculty of Nursing and Midwifery, Khoy University of Medical Sciences, Khoy, Iran. m.akbarbegloo@yahoo.com.
BMC public health
|July 16, 2024
概括
青春期的癌症幸存者由于混乱,心理动荡和身体负担而经历脆弱. 解决这些因素可以改善他们的成年过渡和整体生活质量.
科学领域:
- 在瘤学瘤学.
- 青少年健康 青少年健康
- 定性研究是指质量研究.
背景情况:
- 癌症患病率的增加显著影响了青少年的生活.
- 癌症幸存者面临着更高的脆弱性和负面后果.
- 了解青少年癌症幸存者的看法至关重要.
研究的目的:
- 探索癌症后治疗青少年的感知脆弱性.
- 深入研究青少年癌症幸存者的经历和看法.
- 确定导致这一群体脆弱性的因素.
主要方法:
- 在伊朗,对18名参与者 (青少年,家长,医疗保健提供者,慈善机构代表) 的定性内容分析.
- 在2023年进行的面对面,半结构化的个人访谈.
- 传统的定性内容分析使用MAXQDA10软件进行数据管理.
主要成果:
- 出现了三个类别:青春期早期的混乱,疾病的心理动荡和疾病的身体负担.
- 发现的总体主题是"感知到的脆弱性".
- 数据分析揭示了青少年癌症幸存者面临的多方面的挑战.
结论:
- 识别患者的感知是改善生活质量和过渡到成年人的关键.
- 卫生专业人员可以通过解决知识差距来减轻脆弱性.
- 干预措施应侧重于纠正误解和支持幸存者.
相关概念视频
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Hazard Ratio
109
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
109
Nursing Ethical Principles II
945
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
945
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


